Roche Holding AG (RHHBY)
OTCMKTS · Delayed Price · Currency is USD
54.09
+0.72 (1.35%)
At close: Oct 9, 2026
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
$754,676
Profits / Employee
$147,929
Market Cap
344.27B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Veradigm | 2,300 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 105 |
| Silence Therapeutics | 88 |
| Elite Pharmaceuticals | 65 |
| CytoDyn | 14 |
Roche Holding AG News
- 1 day ago - Genentech announces FDA approval of Tecentriq combination - TheFly
- 1 day ago - FDA Approves Genentech's Tecentriq in Combination With a Fluoropyrimidine and Oxaliplatin for the Adjuvant Treatment of a Certain Type of Stage III Colon Cancer - Business Wire
- 1 day ago - FDA approves Roche's Tecentriq in combination with a fluoropyrimidine and oxaliplatin for the adjuvant treatment of a certain type of stage III colon cancer - GlobeNewsWire
- 3 days ago - Zealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trial - Reuters
- 3 days ago - Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC - PRNewsWire
- 4 days ago - Alector price target raised to $3 from $2 at Morgan Stanley - TheFly
- 5 days ago - Why is Alector Stock (ALEC) 60% Higher Today? - TipRanks
- 5 days ago - Alector soars as Roche licenses Parkinson's therapy for up to $1.27 billion - Reuters